Hemo Organic

{
  "main_header": {
    "sid": 322502,
    "name": "Hemo Organic",
    "stock_name": "Hemo Organic",
    "full_name": "Hemo Organic Ltd",
    "name_url": "stocks-analysis/hemo-organic",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "22.27",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "22.27",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524590,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 67,
    "sector_id": 79,
    "indexname": "India SENSEX",
    "isin": "INE422G01015",
    "curr_date": "Jun 10, 03:30 PM",
    "curr_time": "07:21 AM",
    "last_traded_at": "Jun 10, 03:30 PM IST",
    "bse_nse_vol": "10.6 k",
    "exc_status": "Active",
    "traded_date": "Jun 10, 2026",
    "traded_date_str": "2026 06 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hemo-organic-322502-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Hemo Organic Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-hemo-organic-ltd-latest-results-good-or-bad-4034973",
        "imagepath": "",
        "date": "2026-06-03 19:12:51",
        "description": "Hemo Organic Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹0.93 crores, marking a return to revenue generation after three consecutive quarters of zero sales. However, this figure represents a substantial year-on-year decline of 61.41% from the previous year, indicating a severe contraction in business activity.\n\nThe company faced a net loss of ₹0.51 crores, a stark contrast to the profit of ₹0.37 crores reported in the same quarter last year. This loss was accompanied by an operating margin of -31.18%, a notable decline from the positive margin of 5.81% achieved in Q4 FY25. The widening losses and negative margins underscore ongoing operational inefficiencies and challenges in sustaining profitability.\n\nHemo Organic's balance sheet shows a negative book value of ₹-0.44 per share, reflecting complete equity erosion and raising conce..."
      },
      {
        "title": "Hemo Organic Q4 FY26: Steep Losses Mount as Revenue Collapses 61% - Survival Questions Intensify",
        "link": "https://www.marketsmojo.com/news/result-analysis/hemo-organic-q4-fy26-steep-losses-mount-as-revenue-collapses-61---survival-questions-intensify-4032525",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HemoOrganic_quaterlyResult_4032525.png",
        "date": "2026-06-02 18:36:32",
        "description": "Hemo Organic Ltd., a micro-cap trading and distribution company with a market capitalisation of just ₹7.00 crores, reported deeply troubling results for Q4 FY26 that underscore mounting existential challenges. The company posted a net loss of ₹0.51 crores in the March 2026 quarter, a dramatic reversal from a profit of ₹0.37 crores in the year-ago period. Revenue collapsed by 61.41% year-on-year to just ₹0.93 crores, whilst the company's balance sheet remains mired in negative net worth territory at ₹-0.15 crores."
      },
      {
        "title": "When is the next results date for Hemo Organic Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hemo-organic-ltd-4015041",
        "imagepath": "",
        "date": "2026-05-26 23:17:50",
        "description": "The next results date for Hemo Organic Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Hemo Organic Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-upgraded-to-sell-on-technical-improvements-despite-fundamental-challenges-3976831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HemoOrganicLtd_mojoScore_3976831.png",
        "date": "2026-05-06 08:02:26",
        "description": "Hemo Organic Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score improved to 33.0, reflecting a cautiously optimistic outlook amid volatile market conditions and flat financial performance."
      },
      {
        "title": "Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weaknesses-3967453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HemoOrganicLtd_mojoScore_3967453.png",
        "date": "2026-04-29 08:01:46",
        "description": "Hemo Organic Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 28 April 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance."
      },
      {
        "title": "Hemo Organic Ltd Upgraded to Sell as Technicals Improve Amidst Mixed Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-upgraded-to-sell-as-technicals-improve-amidst-mixed-fundamentals-3956926",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HemoOrganicLtd_mojoScore_3956926.png",
        "date": "2026-04-22 08:01:33",
        "description": "Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 Apr 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain under pressure. Investors should weigh the mildly bullish technical signals against the company’s persistent operational challenges and valuation concerns."
      },
      {
        "title": "Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weaknesses-3950051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HemoOrganicLtd_mojoScore_3950051.png",
        "date": "2026-04-17 08:01:38",
        "description": "Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 Apr 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and challenging valuation metrics, signalling heightened risk for investors amid a volatile market backdrop."
      },
      {
        "title": "Hemo Organic Ltd Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-upgraded-to-sell-a-detailed-analysis-of-quality-valuation-financial-trend-and-technicals-3945137",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HemoOrganicLtd_mojoScore_3945137.png",
        "date": "2026-04-14 08:04:08",
        "description": "Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges, prompting a reassessment of its risk and return profile by analysts."
      },
      {
        "title": "Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hemo-organic-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weaknesses-3935510",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HemoOrganicLtd_mojoScore_3935510.png",
        "date": "2026-04-07 08:04:29",
        "description": "Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 April 2026. This revision reflects a combination of deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors amid challenging market conditions."
      }
    ],
    "total": 196,
    "sid": "322502",
    "stock_news_url": "https://www.marketsmojo.com/news/hemo-organic-322502"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-May-2026",
      "details": "Submission of Newspaper Advertisement of Audited Financial Results for the Quarter and year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday 29Th May 2026",
      "datetime": "29-May-2026",
      "details": "Submission of Audited Financial Results along with Audit Report thereon for the Quarter and year ended on 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Audited Financial Results Along With Audit Report Thereon And Declaration In Respect Of Modified Opinion On Audit Report For The Quarter And Year Ended On 31St March 2026",
      "datetime": "29-May-2026",
      "details": "Submission of Audited financials results along with audit report thereon and declaration in respect of modified opinion on audit report for the quarter and year ended on 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Hemo Organic Ltd latest results good or bad?

2026-06-03 19:12:51

Hemo Organic Ltd's latest financial results for Q4 FY26 reflect significant operational challenges. The company reported net sales of ₹0.93 crores, marking a return to revenue generation after three consecutive quarters of zero sales. However, this figure represents a substantial year-on-year decline of 61.41% from the previous year, indicating a severe contraction in business activity. The company faced a net loss of ₹0.51 crores, a stark contrast to the profit of ₹0.37 crores reported in the same quarter last year. This loss was accompanied by an operating margin of -31.18%, a notable decline from the positive margin of 5.81% achieved in Q4 FY25. The widening losses and negative margins underscore ongoing operational inefficiencies and challenges in sustaining profitability. Hemo Organic's balance sheet shows a negative book value of ₹-0.44 per share, reflecting complete equity erosion and raising conce...

Read full news article

Hemo Organic Q4 FY26: Steep Losses Mount as Revenue Collapses 61% - Survival Questions Intensify

2026-06-02 18:36:32

Hemo Organic Ltd., a micro-cap trading and distribution company with a market capitalisation of just ₹7.00 crores, reported deeply troubling results for Q4 FY26 that underscore mounting existential challenges. The company posted a net loss of ₹0.51 crores in the March 2026 quarter, a dramatic reversal from a profit of ₹0.37 crores in the year-ago period. Revenue collapsed by 61.41% year-on-year to just ₹0.93 crores, whilst the company's balance sheet remains mired in negative net worth territory at ₹-0.15 crores.

Read full news article

When is the next results date for Hemo Organic Ltd?

2026-05-26 23:17:50

The next results date for Hemo Organic Ltd is scheduled for 29 May 2026....

Read full news article

Hemo Organic Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges

2026-05-06 08:02:26

Hemo Organic Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score improved to 33.0, reflecting a cautiously optimistic outlook amid volatile market conditions and flat financial performance.

Read full news article

Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses

2026-04-29 08:01:46

Hemo Organic Ltd has seen its investment rating downgraded from Sell to Strong Sell as of 28 April 2026, reflecting deteriorating technical indicators and persistent fundamental weaknesses. The micro-cap trading and distribution company’s Mojo Score has declined to 23.0, signalling heightened risk for investors amid sideways technical trends and flat financial performance.

Read full news article

Hemo Organic Ltd Upgraded to Sell as Technicals Improve Amidst Mixed Fundamentals

2026-04-22 08:01:33

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 21 Apr 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain under pressure. Investors should weigh the mildly bullish technical signals against the company’s persistent operational challenges and valuation concerns.

Read full news article

Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses

2026-04-17 08:01:38

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 16 Apr 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and challenging valuation metrics, signalling heightened risk for investors amid a volatile market backdrop.

Read full news article

Hemo Organic Ltd Upgraded to Sell: A Detailed Analysis of Quality, Valuation, Financial Trend, and Technicals

2026-04-14 08:04:08

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating upgraded from Strong Sell to Sell as of 13 April 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges, prompting a reassessment of its risk and return profile by analysts.

Read full news article

Hemo Organic Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weaknesses

2026-04-07 08:04:29

Hemo Organic Ltd, a micro-cap player in the Trading & Distributors sector, has seen its investment rating downgraded from Sell to Strong Sell as of 6 April 2026. This revision reflects a combination of deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors amid challenging market conditions.

Read full news article

View All News